LFCR
NASDAQ HealthcareLifecore Biomedical, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
�� 市场数据
| 价格 | $5.38 |
|---|---|
| 成交量 | 218,999 |
| 市值 | 201.63M |
| 贝塔系数 | 0.880 |
| RSI（14日） | 88.7 超买 |
| 200日均线 | $7.13 |
| 50日均线 | $5.79 |
| 52周最高 | $8.98 |
| 52周最低 | $3.63 |
| Forward P/E | -6.48 |
| Price / Book | -14.20 |
🎯 投资策略评分
LFCR 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (91/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🐋 Institutional Whale (4/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 LFCR in your text
粘贴任何文章、记录或帖子 — 工具将提取 LFCR 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.